Sabra Health Care misses Q2 loss estimates but beats revenue forecast

nl.investing.com (Dutch)

Sabra Health Care REIT reported a larger-than-expected loss in Q2 2026, though revenue exceeded Wall Street forecasts and management reaffirmed its raised full-year outlook. The company posted a net loss of $0.10 per share, missing the expected profit of $0.1689, due to a $102.4 million credit loss provision. Revenue reached $235.87 million, beating estimates by 7.4%. Normalized FFO per share rose to $0.38 and AFFO to $0.40 year-over-year. The stock fell 1.09% to $20.39. Management confirmed 2026 guidance for roughly 7% FFO and 8% AFFO growth, supported by senior housing demand and portfolio transitions. The company maintains a 5.82% dividend yield.


With a significance score of 1, this news ranks in the top 65% of today's 33174 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Sabra Health Care misses Q2 loss estimates but beats revenue forecast | News Minimalist